Literature DB >> 11549662

Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy.

R Andrew, H Forsberg, K Cederquist, B R Walker, T Olsson.   

Abstract

Dysfunction of the hypothalamic-pituitary-adrenal axis might contribute to metabolic disturbances frequently encountered in myotonic dystrophy. We hypothesized that abnormal adrenocortical sensitivity to ACTH and/or glucocorticoid metabolism could be important in myotonic dystrophy. We assessed diurnal rhythmicity of saliva cortisol, adrenocortical reactivity by a low-dose (1 microg) Synacthen test, and glucocorticoid metabolism in blood and urine in 42 myotonic dystrophy patients (22 males) and 50 controls (27 males). CTG triplet repeat expansions were quantified by Southern blot. Diurnal rhythmicity of saliva cortisol was flattened in both men and women with myotonic dystrophy, with significantly increased afternoon/evening levels (P < 0.013). The cortisol response to ACTH was associated with increased (CTG)(n) expansions in myotonic dystrophy men and women (P < 0.01). Male myotonic dystrophy patients also had increased activation of cortisol from cortisone by 11beta-hydroxysteroid dehydrogenase type 1. Both men and women with myotonic dystrophy had an increased 5alpha/5beta-reductase ratio (P < 0.05 and P < 0.01, respectively). Cortisol metabolites were related to the genetic defect in myotonic dystrophy men (P < 0.05), whereas ratios reflecting 11beta-hydroxysteroid dehydrogenase type 1 activity in myotonic dystrophy women were positively associated with obesity (P < 0.05). Increased 11beta-hydroxysteroid dehydrogenase type 1 activity and adrenocortical reactivity to ACTH are related to the genetic defect in myotonic dystrophy men, whereas abnormal glucocorticoid metabolism is associated with alterations in body composition in female myotonic dystrophy patients. These disturbances may explain altered circulating cortisol levels and contribute to features of the metabolic syndrome in myotonic dystrophy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549662     DOI: 10.1210/jcem.86.9.7865

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Pre-analytic considerations for the proper assessment of hormones of the hypothalamic-pituitary axis in epidemiological research.

Authors:  Rachel L Derr; Scott J Cameron; Sherita Hill Golden
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

2.  Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus.

Authors:  Fan Yao; Li Chen; Zheng Fan; Fei Teng; Yali Zhao; Fengying Guan; Ming Zhang; Yanjun Liu
Journal:  Bioorg Med Chem Lett       Date:  2017-07-15       Impact factor: 2.823

3.  Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.

Authors:  Janice M Paterson; Nicholas M Morton; Catherine Fievet; Christopher J Kenyon; Megan C Holmes; Bart Staels; Jonathan R Seckl; John J Mullins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

4.  Hormonal and metabolic gender differences in a cohort of myotonic dystrophy type 1 subjects: a retrospective, case-control study.

Authors:  M Spaziani; A Semeraro; E Bucci; F Rossi; M Garibaldi; M A Papassifachis; C Pozza; A Anzuini; A Lenzi; G Antonini; A F Radicioni
Journal:  J Endocrinol Invest       Date:  2019-11-30       Impact factor: 4.256

5.  Vitamin D deficiency in myotonic dystrophy type 1.

Authors:  Chiara Terracciano; Emanuele Rastelli; Maria Morello; Monica Celi; Elisabetta Bucci; Giovanni Antonini; Ottavia Porzio; Umberto Tarantino; Rossella Zenobi; Roberto Massa
Journal:  J Neurol       Date:  2013-06-11       Impact factor: 4.849

Review 6.  11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

Authors:  Karen Chapman; Megan Holmes; Jonathan Seckl
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

7.  The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome.

Authors:  Minghan Wang
Journal:  Nutr Metab (Lond)       Date:  2005-02-02       Impact factor: 4.169

8.  Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1.

Authors:  Moffat J Nyirenda; Roderick Carter; Justin I Tang; Annick de Vries; Christina Schlumbohm; Stephen G Hillier; Frank Streit; Michael Oellerich; Victor W Armstrong; Eberhard Fuchs; Jonathan R Seckl
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

9.  Tissue-specific increases in 11beta-hydroxysteroid dehydrogenase type 1 in normal weight postmenopausal women.

Authors:  Therése Andersson; Kotryna Simonyte; Ruth Andrew; Magnus Strand; Jonas Burén; Brian R Walker; Cecilia Mattsson; Tommy Olsson
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

10.  RARE POMC MUTATION IN A PATIENT WITH MYOTONIC DYSTROPHY TYPE 1 AND ADRENOCORTICOTROPIN HYPERRESPONSE TO CORTICOTROPIN-RELEASING HORMONE.

Authors:  Silvia Cantara; Francesco Chiofalo; Cristina Ciuoli; Carlotta Marzocchi; Maria Teresa Dotti; Maccora Carla; Maria Grazia Castagna; Fabio Giannini
Journal:  AACE Clin Case Rep       Date:  2018-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.